Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Go WilliamChief Medical Officer | Grant or award | A | — 44.0K sh | Feb 4, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 7,019 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Dixon Jonathan V.GENERAL COUNSEL | Grant or award | A | — 26.1K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Grant or award | A | — 5,673 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Howze YalondaINTERIM CEO & PRESIDENT | Option exercise | M | — 1,673 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Regan John PSEVP, Chief Risk Officer | Tax withholding | F | $23K 1,835 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Bohen SeanDirector, PRESIDENT AND CEO | Grant or award | A | — 850.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Honorable Colette DEVP CLO Compliance & Corp Sec | Grant or award | A | — 12.8K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kim Peter Sung-JipSVP & GM Industrial Business | Option exercise | M | — 5,488 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Adamchak MarkPrincipal Accounting Officer | Grant or award | A | — 10.9K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Torres Isaac P.Director | Grant or award | A | $14K 212 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 9 | Link David ForrestDirector | Grant or award | A | — 771 sh | Feb 4, 2026 traded Feb 4, 2026 |
| 9 | Shaikh KashifDirector, President and CEO | Grant or award | A | — 238.2K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Go WilliamChief Medical Officer | Grant or award | A | — 154.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Bachrodt AmySVP, Finance | Open-market sale · 10b5-1 plan | SELL | $8,830 200 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $51K 2,492 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Fox-Geen JeremyChief Financial Officer | Tax withholding | F | $248K 3,877 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Allaire JeremyDirector, Chairman and CEO | Tax withholding | F | $537K 8,404 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $61K 2,970 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Okupe OluyemiChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $139K 5,262 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 8 | Gummadi SuryaPresident - Americas | Open-market sale · 10b5-1 plan | SELL | $144K 1,728 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 6 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $8,388 720 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 6 | Allaire JeremyDirector, Chairman and CEO | Option exercise | M | — 2,434 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 6 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $108K 10.0K sh | Feb 4, 2026 traded Feb 4, 2026 |
| 6 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $159K 14.7K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Novack Jeffrey AdamSecretary and General Counsel | Grant or award | A | — 4,342 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Saldanha CraigChief Product Officer | Open-market sale · 10b5-1 plan | SELL | $33K 1,200 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Randhawa SimratEVP, Head of R&D | Grant or award | A | — 150.0K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Russotti GregorySee Remarks | Grant or award | A | — 265.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Nelson Jeffrey EdwardChief Operating Officer | Grant or award | A | — 204.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Zojwalla NaseemCHIEF MEDICAL OFFICER | Grant or award | A | — 106.3K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Bharucha DavidChief Medical Officer | Grant or award | A | — 136.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Heeson LeeEVP, Head of Incyte Intl | Tax withholding | F | $11K 111 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Nelson Jeffrey EdwardChief Operating Officer | Grant or award | A | — 136.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Chuang Patrick T.Senior VP, Memory Design | Grant or award | A | — 20.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Bharucha DavidChief Medical Officer | Grant or award | A | — 204.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Zojwalla NaseemCHIEF MEDICAL OFFICER | Grant or award | A | — 250.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Pfeiffenberger BrentDirector, President and CEO | Grant or award | A | — 945.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Naude PierreDirector | Grant or award | A | — 3,516 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Vultaggio VincentPAO and PFO | Open-market sale · 10b5-1 plan | SELL | $6,477 2,540 sh | Feb 4, 2026 traded Feb 2, 2026 |